Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€1.98
09.03.21
€3.00
-0.51%
20.03.21

Could be very worthwhile Investment >20% year
buy
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€1.98
09.03.21
-
-0.51%
21.03.21

Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€41.76
09.03.21
-
22.08%
21.03.21

Could be very worthwhile Investment >20% year
buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€20.05
09.03.21
€28.00
09.03.22
15.36%
10.03.22

buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€48.45
09.03.21
-
09.03.22
-76.53%
17.06.21

Could be very worthwhile Investment >20% year
buy
GSK plc

Start price
Target price
Perf. (%)
€14.97
09.03.21
€22.00
09.03.22
25.18%
10.03.22

High dividend yield expected
Good rating
Very small cyclical dependencies
Fair valuation
buy
Zynerba Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€3.50
08.03.21
€5.00
08.03.22
-49.79%
09.03.22

Could be worthwhile Investment >10% per year
buy
Bayer AG ADR

Start price
Target price
Perf. (%)
€13.10
08.03.21
€14.00
3.05%
10.03.21

EBIT growth >5% per year expected
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€81.24
08.03.21
-
08.03.22
-5.02%
22.03.21

buy
Aphria Inc.

Start price
Target price
Perf. (%)
€13.38
08.03.21
€15.00
13.62%
10.03.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€82.98
08.03.21
-
08.03.22
-72.98%
09.03.22

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Good rating
Standard Investments for future growth
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€26.42
08.03.21
€35.00
08.03.22
10.52%
20.03.21

buy
Vaxart Inc.

Start price
Target price
Perf. (%)
€5.15
08.03.21
-
12.62%
21.03.21

buy
Valneva SE

Start price
Target price
Perf. (%)
€10.68
07.03.21
€11.00
07.03.22
26.50%
07.03.22

buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€4.72
07.03.21
-
-0.42%
22.03.21

Risky Investment
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€36.19
07.03.21
-
07.03.22
-62.14%
08.03.22

EBIT growth >5% per year expected
Capable Management
Could be worthwhile Investment >10% per year
Little innovation
Epizyme Inc.

Start price
Target price
Perf. (%)
€7.95
07.03.21
-
07.03.22
-4.40%
20.03.21

buy
Paion AG

Start price
Target price
Perf. (%)
€2.23
07.03.21
€5.00
07.03.22
-47.17%
08.03.22

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.98
06.03.21
-
06.03.22
27.92%
20.09.21

buy
Nanorepro AG

Start price
Target price
Perf. (%)
€18.60
06.03.21
-
06.03.22
-59.84%
21.12.21

Could be very worthwhile Investment >20% year
X T L Biopharmaceuticals Ltd ADR

Start price
Target price
Perf. (%)
€2.80
06.03.21
€1.00
1.43%
20.03.21

Evofem Biosciences Inc.

Start price
Target price
Perf. (%)
€30.53
06.03.21
€0.000
17.69%
20.03.21

buy
X T L Biopharmaceuticals Ltd ADR

Start price
Target price
Perf. (%)
€2.80
06.03.21
-
06.03.22
-25.00%
07.03.22

Could be very worthwhile Investment >20% year
Zogenix Inc.

Start price
Target price
Perf. (%)
€17.40
05.03.21
-
05.03.22
-13.85%
15.07.21

Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€57.50
05.03.21
-
05.03.22
36.00%
30.07.21